Chemed Corporation 2026 Jefferies Healthcare Services and Technology Conference
Review the key takeaways and the transcript of this earnings call.
- Chemed increased guidance in the second quarter, with results broadly in line with expectations and slightly better than expected.
- Roto-Router’s top line is growing as the business works toward stabilization despite higher paid-lead costs and lower free-lead visibility.
- VITAS exceeded expectations and expanded margins through overall business management, personnel management, labor management, and operational execution.
- VITAS’s recent CON awards in Florida exceeded expectations and contributed strongly to margin expansion.
- Roto-Router’s billing centralization resulted in 33 fewer employees doing bidding and billing, an average job size increase of more than 300 dollars per job, and a one-percentage-point improvement in the collection rate.
- During the pandemic, Chemed received 82 million dollars in federal pandemic relief and used 100% of it for additional vacation pay and hiring and retention efforts.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Awesome. Good morning, and thank you again for joining us for the 2026 Jefferies Global Healthcare Conference. I'm Brian Tanquilut, healthcare services analyst here at Jefferies. The next company we have is Chemed. They're the largest operator of hospice services in the U.S., and also they own Roto-Rooter. With us this morning are Kevin McNamara, company CEO, and Joel Wherley, CEO of VITAS, the hospice business. Kevin, Joel, thank you so much for joining us. I'll start, Kevin, maybe if you can start with the state of the union, how the second quarter played out, and how you're thinking about the back half of the year.
Sure. Let me start by saying that the second quarter, we increased guidance. It was pretty much things happened as we expected, only a little bit better. The trends again, were solid. I would characterize it as, let's start with the tougher one, Roto-Rooter. Roto-Rooter, the goal this year was a little more stabilization. It's difficult. I won't bore everybody with the market issue. The only problem Roto-Rooter has is the fact that we face some negative comparisons on marketing expenses because our percent of free leads has gone from basically close to 60% to now just under 40% in the course of about two years. It's just efforts by Google to say, "If we have companies that are advertising, we should bury them in the free sections, and they should pay for their leads." It's their business. That's what they've determined to do, and we're just dealing with that.
It's a new normal. We have a lot of plumbing companies scrambling, paying a lot more. We've gone from about $50 a lead to $120, $125 a lead on the paid side, and there's more companies vying for those. Roto-Rooter's done a pretty good job of paying a little bit more money, but we're getting the leads. They're not falling. They're getting. Our top line is growing. That's the first stage, stabilization of the business. That is the top line and looking for growth of the top line. Dealing with margin as we fight the battles with Google, and again, it's a battle where our visibility on the free side falls a little bit, and we make some effort, and then we increase it.
Net effect is a stable Roto-Rooter business, and I characterize it as, from an investment standpoint, what we want is Roto-Rooter to be stable and to get out of VITAS's way because VITAS is doing great and exceeding our expectations. Bouncing back from an unusual situation in Florida last year where we had Medicare cap exposure of a relatively small amount, $19 million. The day we announced that, the stock fell 100 points, about well over $1 billion in value. VITAS has dealt with that issue, and as I said, exceeding expectations this year. The good news about hospice is such that it's a very predictable business. In other words, Roto-Rooter, we don't know what our sales are going to be tomorrow. We'll just wait to see how the phone rings.
Joel knows within a couple hundred thousand dollars what your sales are going to be tomorrow. It is a very predictable business. It is one that during periods when you are struggling, it is like an aircraft carrier, a little tough to turn around. On the other side, when things are going well, it is steady as she goes. Our outlook is just stabilization of Roto-Rooter, get out of VITAS's way because they are doing great.
That is awesome. Maybe Joel, since Kevin highlighted VITAS and the strength there, if you can walk us through how you are thinking about the sustainability of the margin gains that you have delivered there. I think you had an EHR rollout and a few other initiatives that are helping drive margin and growth. Walk us through some of that.
Yeah. We have realized some improvement because of the EHR. In reality, when we look at our margin expansion, which we planned for, and have exceeded expectations, it is really because the overall management of the business. Personnel management, although while we have had marginal expansion with labor management, we have no concerns about our current labor force being able to expand it to meet the expectations of growth, both in Florida and throughout the country. The other component to that is, as we looked at the year, we knew the strategy that we put into place, and employed going back to last year to mitigate the cap liability that had been generated was going to cause marginal compression. We planned for that and then laid out the strategy of which we would expand that marginal improvement throughout the course of the year.
Our two recognitions of expansion of that margin contributed then to restating guidance twice, unprecedented for the organization.
Positively in a very positive way.
We planned for it. We're ahead of expectations, but also recognize where we will most likely finish the year and then plan for next year.
Joel, maybe if I can double-click on that, the raised expectations. Is that just a matter of just execution, or is this seeing benefits from the Florida expansions you had in Pinellas?
Yeah. Yeah. The most recent expansions in CON awards within the state of Florida have exceeded expectations.
Their growth has had a very strong, positive contribution to that marginal expansion. But it is through delivering on a strategy and ensuring that from an operational perspective, we are appropriately managing the business on a day-to-day basis.
One of the reasons, I say, to the extent that those new starts do so well, they create cap cushion. A lot of it. Florida's all one program for us. What it really demonstrates is there's plenty of business in Florida. There's limitations on it. It's Medicare cap liability. If Joel is able to, let's say, run. We talk about a range where we want our hospital admissions, which are low or zero profit margin associated with. If those run at 44%, okay, it hits your margin, your profitability a little bit, but you create cap cushion.
Sure. To the extent that you have other entities, these new starts that are doing better than expected and creating a lot more cap cushion, he can run at the lower end of that, 42%.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
3 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
